WW Similar Chart Price Prediction
The price of WW is predicted to go up 32.52%, based on the high correlation periods with DYAI. The similarity of these two price pattern on the periods is 98.84%.
WW
DYAI
Up: 32.52%Similarity: 98.84%
WW Revenue Forecast
WW EPS Forecast
WW FAQs
What is bull’s view on WW?
What is bear's view on WW?
What is WW revenue forecast for next quarter？
What is WW eps forecast for next quarter？
WW Analyst's Forecast
Stephanie Davis
Barclays
Sell
2024-10-10
Price Target
$0.75
Downside
-61.73%
Barclays is "increasingly cautious" on WeightWatchers (WW) following a recent study from Novo Nordisk (NVO) that yielded negative datapoints around the investigated differences between the company's own manufactured semaglutide and liraglutide against compounders. While the firm expects compounding will remain a presence until supply constraints ease it continues to view WW's move toward compounded GLP-1s as "having more risk than reward" and with WW's stock up nearly 150% since the company announced its compounded GLP-1 offering, Barclays sees incremental downside risk to shares. The firm reiterates an Underweight rating and 75c price target on WW shares.
